» Articles » PMID: 23943864

Shiftwork and Prostate-specific Antigen in the National Health and Nutrition Examination Survey

Overview
Specialty Oncology
Date 2013 Aug 15
PMID 23943864
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Shiftwork has been implicated as a risk factor for prostate cancer. Results from prior studies have been mixed but generally support an association between circadian disruption and prostate cancer. Our aim was to investigate the relationship between shiftwork and prostate-specific antigen (PSA) test obtained as part of the National Health and Nutrition Examination Survey (NHANES) study.

Methods: We combined three NHANES surveys (2005-2010) to obtain current work schedule among employed men aged 40 to 65 years with no prior history of cancer (except nonmelanoma skin cancer). Men who reported working regular night shifts or rotating shifts were considered shiftworkers. We obtained the total and percentage free PSA test results for these men and dichotomized total PSA into less than 4.0 ng/mL or 4.0 ng/mL or greater and total PSA of 4.0 ng/mL or greater combined with percentage free PSA less than or equal to 25%. Using multivariable logistic regression models, we compared PSA level among current shiftworkers and nonshiftworkers. All statistical tests were two-sided.

Results: We found a statistically significant, age-adjusted association between current shiftwork and elevated PSA at the 4.0 ng/mL or greater level (odds ratio = 2.48, 95% confidence interval [CI] = 1.08 to 5.70; P = .03). The confounder-adjusted odds ratio was 2.62 (95% CI = 1.16 to 5.95; P = .02). The confounder-adjusted odds ratio for those with total PSA of 4.0 ng/mL or greater and free PSA less than or equal to 25% was 3.13 (95% CI = 1.38 to 7.09; P = .01).

Conclusions: We observed a strong positive association with shiftwork and elevated PSA level. Our data support the notion that sleep or circadian disruption is associated with elevated PSA, indicating that shiftworking men likely have an increased risk of developing prostate cancer.

Citing Articles

Associations of HALP score with serum prostate-specific antigen and mortality in middle-aged and elderly individuals without prostate cancer.

Chen Z, Zhang Y, Dan M, Hong X, Chen S, Zhong X Front Oncol. 2024; 14:1419310.

PMID: 39372874 PMC: 11449680. DOI: 10.3389/fonc.2024.1419310.


Associations between inflammatory burden index, prostate cancer, and mortality among middle-aged and elderly individuals.

Deng J, Hua J, Zeng T, Que H, Zhang Q, Li Q World J Urol. 2024; 42(1):538.

PMID: 39325178 DOI: 10.1007/s00345-024-05241-5.


Circadian rhythms and breast cancer: from molecular level to therapeutic advancements.

Li D, Zhou T, Gao J, Wu G, Yang G J Cancer Res Clin Oncol. 2024; 150(9):419.

PMID: 39266868 PMC: 11393214. DOI: 10.1007/s00432-024-05917-w.


A review for the impacts of circadian disturbance on urological cancers.

Li T, Jiang Y, Bai Y, Jiang K, Du G, Chen P Sleep Biol Rhythms. 2024; 22(2):163-180.

PMID: 38524168 PMC: 10959858. DOI: 10.1007/s41105-023-00500-1.


Effectiveness of caffeine and blue-enriched light on cognitive performance and electroencephalography correlates of alertness in a spaceflight robotics simulation.

Flynn-Evans E, Rueger M, Liu A, Galvan-Garza R, Natapoff A, Oman C NPJ Microgravity. 2023; 9(1):93.

PMID: 38114500 PMC: 10730879. DOI: 10.1038/s41526-023-00332-w.


References
1.
Morgan L, Hampton S, Gibbs M, Arendt J . Circadian aspects of postprandial metabolism. Chronobiol Int. 2003; 20(5):795-808. DOI: 10.1081/cbi-120024218. View

2.
Richards J, Gumz M . Advances in understanding the peripheral circadian clocks. FASEB J. 2012; 26(9):3602-13. PMC: 3425819. DOI: 10.1096/fj.12-203554. View

3.
Conlon M, Lightfoot N, Kreiger N . Rotating shift work and risk of prostate cancer. Epidemiology. 2006; 18(1):182-3. DOI: 10.1097/01.ede.0000249519.33978.31. View

4.
Orsted D, Nordestgaard B, Jensen G, Schnohr P, Bojesen S . Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population. Eur Urol. 2011; 61(5):865-74. DOI: 10.1016/j.eururo.2011.11.007. View

5.
Zhu Y, Zheng T, Stevens R, Zhang Y, Boyle P . Does "clock" matter in prostate cancer?. Cancer Epidemiol Biomarkers Prev. 2006; 15(1):3-5. PMC: 2366206. DOI: 10.1158/1055-9965.EPI-05-0631. View